The effectiveness and safety of dupilumab in the management of refractory prurigo nodularis in 45 Chinese patients: A real‐life observational study

Prurigo Nodularis: Epidemiology and Clinical Features

(2020) Amy H. Huang et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Effectiveness and safety of dupilumab for the treatment of prurigo nodularis in a French multicenter adult cohort of 16 patients

(2019) A. Calugareanu et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Dupilumab Treatment for Generalized Prurigo Nodularis

(2018) Kristen M. Beck et al.   JAMA Dermatology

Reduced Itch Associated With Dupilumab Treatment In 4 Patients With Prurigo Nodularis

(2018) Nicholas K. Mollanazar et al.   JAMA Dermatology

Clinical Features of Adult/Adolescent Atopic Dermatitis and Chinese Criteria for Atopic Dermatitis

(2016) Jian-Zhong Zhang et al.   CHINESE MEDICAL JOURNAL

Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis

(2014) Lisa A. Beck et al.   NEW ENGLAND JOURNAL OF MEDICINE

Psychological factors involved in prurigo nodularis: A pilot study

(2010) Carla Dazzi et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

Prurigo nodularis: systematic analysis of 58 histological criteria in 136 patients

(2009) Nils Weigelt et al.   JOURNAL OF CUTANEOUS PATHOLOGY